ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 145 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $691 | +297.1% | 28,827 | +180.4% | 0.07% | +209.1% |
Q4 2022 | $174 | -100.0% | 10,281 | -80.2% | 0.02% | -82.0% |
Q2 2022 | $816,000 | +272.6% | 51,848 | +876.2% | 0.12% | +238.9% |
Q1 2021 | $219,000 | -22.3% | 5,311 | -18.4% | 0.04% | -21.7% |
Q4 2020 | $282,000 | – | 6,511 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DFPG INVESTMENTS, LLC | 183,803 | $9,359,000 | 5.00% |
DAFNA Capital Management LLC | 229,652 | $9,852,000 | 3.20% |
HealthCor Management, L.P. | 1,594,452 | $68,402,000 | 2.74% |
Capital Impact Advisors, LLC | 110,000 | $4,719,000 | 1.40% |
Cormorant Asset Management, LP | 700,000 | $30,030,000 | 1.16% |
ARK Investment Management | 2,495,842 | $107,072,000 | 0.64% |
Millrace Asset Group, Inc. | 18,087 | $776,000 | 0.63% |
COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,168,000 | 0.54% |
Endurant Capital Management LP | 34,485 | $1,479,000 | 0.44% |
HealthCor Management, L.P. | 200,000 | $8,580,000 | 0.34% |